Impact of complete lockdown on total infection and death rates: A hierarchical cluster analysis

被引:55
作者
Ghosal, Samit [1 ]
Bhattacharyya, Rahul [1 ]
Majumder, Milan [1 ]
机构
[1] Nightingale Hosp, Kolkata, India
关键词
Lockdown; SARS-CoV-2; Infection; Death; Cluster analysis;
D O I
10.1016/j.dsx.2020.05.026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction and Aims: Retarding the spread of SARS-CoV-2 infection by preventive strategies is the first line of management. Several countries have declared a stringent lockdown in order to enforce social distancing and prevent the spread of infection. This analysis was conducted in an attempt to understand the impact of lockdown on infection and death rates over a period of time in countries with declared lock-down. Material and methods: A validated database was used to generate data related to countries with declared lockdown. Simple regression analysis was conducted to assess the rate of change in infection and death rates. Subsequently, a k-means and hierarchical cluster analysis was done to identify the countries that performed similarly. Sweden and South Korea were included as counties without lockdown in a second-phase cluster analysis. Results: There was a significant 61% and 43% reduction in infection rates 1-week post lockdown in the overall and India cohorts, respectively, supporting its effectiveness. Countries with higher baseline infections and deaths (Spain, Germany, Italy, UK, and France-cluster 1) fared poorly compared to those who declared lockdown early on (Belgium, Austria, New Zealand, India, Hungary, Poland and Malaysia-cluster 2). Sweden and South Korea, countries without lock-down, fared as good as the countries in cluster 2. Conclusion: Lockdown has proven to be an effective strategy is slowing down the SARS-CoV-2 disease progression (infection rate and death) exponentially. The success story of non-lock-down countries (Sweden and South Korea) need to be explored in detail, to identify the variables responsible for the positive results. (C) 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:707 / 711
页数:5
相关论文
共 6 条
[1]   SARS-CoV-2 Vaccines: Status Report [J].
Amanat, Fatima ;
Krammer, Florian .
IMMUNITY, 2020, 52 (04) :583-589
[2]  
Ghosal S, 2020, FREQUENCY TESTING CO, DOI [10.1101/2020.04.01.20047373v1, DOI 10.1101/2020.04.01.20047373V1]
[3]   The socio-economic implications of the coronavirus pandemic (COVID-19): A review [J].
Nicola, Maria ;
Alsafi, Zaid ;
Sohrabi, Catrin ;
Kerwan, Ahmed ;
Al-Jabir, Ahmed ;
Iosifidis, Christos ;
Agha, Maliha ;
Agha, Riaz .
INTERNATIONAL JOURNAL OF SURGERY, 2020, 78 :185-193
[4]   Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base [J].
Taccone, Fabio S. ;
Gorham, Julie ;
Vincent, Jean-Louis .
LANCET RESPIRATORY MEDICINE, 2020, 8 (06) :539-541
[5]   Chloroquine is a potent inhibitor of SARS coronavirus infection and spread [J].
Vincent, Martin J. ;
Bergeron, Eric ;
Benjannet, Suzanne ;
Erickson, Bobbie R. ;
Rollin, Pierre E. ;
Ksiazek, Thomas G. ;
Seidah, Nabil G. ;
Nichol, Stuart T. .
VIROLOGY JOURNAL, 2005, 2 (1)
[6]   Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro [J].
Wang, Manli ;
Cao, Ruiyuan ;
Zhang, Leike ;
Yang, Xinglou ;
Liu, Jia ;
Xu, Mingyue ;
Shi, Zhengli ;
Hu, Zhihong ;
Zhong, Wu ;
Xiao, Gengfu .
CELL RESEARCH, 2020, 30 (03) :269-271